Sputnik V became the world’s first registered Covid vaccine based on a human adenoviral vector platform Dr. Reddy’s Laboratories and the Russian Direct Investment Fund (RDIF) announced on Tuesday the start of adaptive phase 2/3 clinical trials for the COVID-19 Sputnik V vaccine in India after receiving the necessary authorization …
Read More »
HYDERABAD: Pharmaceutical actor Hetero Labs has partnered with Russian sovereign wealth fund Russian Direct Investment Fund (RDIF) to manufacture more than 100 million doses of the Russian Covid-19 Sputnik V vaccine in India. The Sputnik V will be manufactured by Hetero’s biologics division, Hetero Biopharma, at Jadcherla in Hyderabad, with …
Read More »
MUMBAI: Sputnik V Covid-19 of Russia vaccine, which reported an efficiency of more than 95%, will be twice as cheap as Pfizer and Moderna with similar positive results. Sputnik V, developed by Gamaleya Institute Y RDIF (Russian Direct Investment Fund), will be priced at less than $ 20 per person …
Read More »
NEW DELHI: The global race to create vaccines against the novel coronavirus has entered a critical stretch, with Pfizer and Moderna releasing very promising final test data that has raised the hopes of nations struggling to combat the pandemic. Pfizer, which reported 95% efficiency, has now applied for early regulatory …
Read More »
KANPUR: The first batch of Russia’s Sputnik V vaccine for Covid-19 is likely to arrive at Ganesh Shankar Vidyarthi Medical College in Kanpur next week, where phase 2 and phase 3 human clinical trials of the vaccine. The decision to conduct human clinical trials of the vaccine was made after …
Read More »
NEW DELHI The Russian Direct Investment Fund (RDIF) has signed a pact with Delhi-based pharmaceutical company Mankind Pharma for the marketing and distribution of its Sputnik V vaccine, two sources with knowledge of the matter said. “It depends on how many doses you give to humanity. RDIF has deals with …
Read More »
NEW DELHI: The Serum Institute of India and Bharat Biotech are expected to conduct advanced stage clinical trials of intranasal Covid-19 vaccines in the coming months once they receive regulatory approval, Union Health Minister Harsh said on Sunday Vardhan. Vardhan said the late-stage trial typically involves thousands of participants, sometimes …
Read More »
HYDERABAD: After India’s drug regulator rejected Dr. Reddy’s Laboratories Ltd’s proposal earlier this month to conduct phase 3 direct human trials for the Russian Covid-19 Sputnik V vaccine, the company and fund Russian investment sovereign Russian Direct Investment Fund (RDIF) have now received the go-ahead from Drug Control of India …
Read More »
NEW DELHI: India’s drug regulator rejected a proposal from Dr Reddy’s Laboratories Ltd to conduct a large study in the country to evaluate Russia’s Sputnik-V Covid-19 vaccine and asked it to first test the vaccine in a further trial little. Recommendations from a panel of experts from the Central Standard …
Read More »
NEW DELHI: The government plans to administer around 40-50 crore of covid-19 vaccines to 20-25 crore of Indians in July. The Center, together with the states, is also preparing a list of priority population groups, especially front-line health workers, who would receive vaccines, Union Health Minister Harsh Vardhan said on …
Read More »